1. Home
  2. UPLD vs ATNM Comparison

UPLD vs ATNM Comparison

Compare UPLD & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$1.42

Market Cap

52.0M

Sector

Technology

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.37

Market Cap

47.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
ATNM
Founded
2010
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.0M
47.1M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
UPLD
ATNM
Price
$1.42
$1.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.50
$4.00
AVG Volume (30 Days)
208.6K
182.4K
Earning Date
11-06-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$235,591,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$1.39
$1.03
52 Week High
$4.98
$2.41

Technical Indicators

Market Signals
Indicator
UPLD
ATNM
Relative Strength Index (RSI) 29.43 42.17
Support Level $1.40 $1.57
Resistance Level $1.53 $1.72
Average True Range (ATR) 0.10 0.10
MACD 0.01 -0.02
Stochastic Oscillator 9.37 5.41

Price Performance

Historical Comparison
UPLD
ATNM

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: